logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yoshito Komatsu

Hokkaido University Hospital
H指数:54
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial

ctDNA阳性的结直肠癌患者术后辅助化疗: 一项随机3期试验

Nature Medicine
IF50
2026-06-080
OAAI
Hideaki Bando; Jun Watanabe; Yusuke Takahashi; Masahito Kotaka; Nobuhisa Matsuhashi; Eiji Oki; Yoshito Komatsu; Manabu Shiozawa; Keiji Hirata; Yuji Miyamoto; Masanobu Takahashi; Kentaro Yamazaki; Dai Manaka; Akiyoshi Kanazawa; Yi-Hsin Liang; Kun-Huei Yeh; Yuko Watsuji; Yuko Yamamoto; Makoto Fukui; Shruti Sharma; Vasily N. Aushev; Adham Jurdi; Matthew Rabinowitz; Minetta C. Liu; Alexey Aleshin; Ichiro Takemasa; Daisuke Kotani; Akihiro Sato; Toshihiro Misumi; Yoshiaki Nakamura; Qian Shi; Hiroya Taniguchi; Takayuki Yoshino; Takeshi Kato
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway

既往抗EGFR治疗和基线ctDNA分析对帕妥珠单抗联合曲妥珠单抗在HER2扩增转移性结直肠癌中的疗效影响：TRIUMPH/MyPathway整合分析

ESMO Open
IF8.3
2026-05-270
OAAI
Y. Matsubara; M. Wakabayashi; W. Okamoto; T. Kato; T. Esaki; K. Kato; Y. Komatsu; T. Masuishi; T. Nishina; H. Bando; T. Misumi; M. Fukui; S. Matsuda; Y. Ikeda; J. Malato; K. Schulze; R. Price; A. Sato; T. Yoshino; Y. Nakamura
A multicenter phase II study of eribulin for BRAF V600E mutant metastatic colorectal cancer: the BRAVERY study (EPOC1701)

一项关于厄洛替尼用于BRAF V600E突变型转移性结直肠癌的多中心II期研究：BRAVERY研究（EPOC1701）

ESMO Open
IF8.3
2025-10-090
OAAI
T. Masuishi; H. Taniguchi; D. Kotani; H. Bando; Y. Komatsu; E. Shinozaki; Y. Sunakawa; T. Satoh; T. Nishina; T. Esaki; M. Wakabayashi; S. Nomura; K. Takahashi; H. Ono; N. Hirano; N. Fujishiro; N. Fuse; A. Sato; Y. Sakamoto; N. Kuramoto; I. Miki; H. Ichiki; Y. Nakamura; G. Sharma; S. Skrzypczak; E. Schultz; C. Kingsford; A. Ohtsu; T. Yoshino
Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors

循环肿瘤DNA分析指导下的晚期消化道肿瘤靶向治疗

NATURE MEDICINE
IF50
2024-09-162
OAAI
Nakamura, Yoshiaki; Ozaki, Hiroshi; Ueno, Makoto; Komatsu, Yoshito; Yuki, Satoshi; Esaki, Taito; Taniguchi, Hiroya; Sunakawa, Yu; Yamaguchi, Kensei; Kato, Ken; Denda, Tadamichi; Nishina, Tomohiro; Takahashi, Naoki; Satoh, Taroh; Yasui, Hisateru; Satake, Hironaga; Oki, Eiji; Kato, Takeshi; Ohta, Takashi; Matsuhashi, Nobuhisa; Goto, Masahiro; Okano, Naohiro; Ohtsubo, Koushiro; Yamazaki, Kentaro; Yamashita, Riu; Iida, Naoko; Yuasa, Mihoko; Bando, Hideaki; Yoshino, Takayuki
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC

Quattro-ii随机试验: CAPOXIRI bevacizumab与FOLFOXIRI bevacizumab作为mCRC患者的一线治疗

MED
IF11.8
2024-09-010
OA
Bando, Hideaki; Kotani, Daisuke; Satake, Hironaga; Hamaguchi, Tetsuya; Shiozawa, Manabu; Kotaka, Masahito; Masuishi, Toshiki; Yasui, Hisateru; Kagawa, Yoshinori; Komatsu, Yoshito; Oki, Eiji; Yamamoto, Yoshiyuki; Kawakami, Hisato; Misumi, Toshihiro; Taniguchi, Hiroya; Yamazaki, Kentaro; Muro, Kei; Yoshino, Takayuki; Kato, Takeshi; Tsuji, Akihito
A phase I study of PARP inhibitor (niraparib) plus HSP90 inhibitor (pimitespib) in solid tumors: The NiraPim (EPOC2102) study

一项关于PARP抑制剂（niraparib）联合HSP90抑制剂（pimitespib）在实体瘤中的I期研究：NiraPim（EPOC2102）研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Nakajima, H.; Kubota, H.; Tsukamoto, K.; Eiraku, T.; Takahashi, K.; Kobayashi, K.; Komatsu, Y.; Kotani, H.; Kato, T.; Wakabayashi, M.; Fujisawa, T.; Nakamura, Y.; Ohashi, A.; Yoshino, T.; Sato, A.; Naito, Y.
A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2024-08-142
OA
Nakatsumi, Hiroshi; Komatsu, Yoshito; Harada, Kazuaki; Kawamoto, Yasuyuki; Yuki, Satoshi; Sawada, Kentaro; Ishiguro, Atsushi; Sogabe, Susumu; Ando, Takayuki; Sasaki, Yusuke; Yoshikawa, Ayumu; Nakamura, Michio; Dazai, Masayoshi; Tateyama, Miki; Muto, Osamu; Kotaka, Masahito; Sagawa, Tamotsu; Muranaka, Tetsuhito; Hatanaka, Kazuteru; Takagi, Ryo; Sakata, Yu
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine

Scrum-monstar癌症组学生态系统: 努力实现精准医学的飞跃

CANCER DISCOVERY
IF33.3
2024-07-161
OAAI
Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Fujisawa, Takao; Imai, Mitsuho; Shibuki, Taro; Iida, Naoko; Ozaki, Hiroshi; Nonomura, Norio; Morizane, Chigusa; Iwata, Hiroji; Okano, Susumu; Yamagami, Wataru; Yamazaki, Naoya; Kadowaki, Shigenori; Taniguchi, Hiroya; Ueno, Makoto; Boku, Shogen; Oki, Eiji; Komatsu, Yoshito; Yuki, Satoshi; Makiyama, Akitaka; Otsuka, Tomoyuki; Hara, Hiroki; Okano, Naohiro; Nishina, Tomohiro; Sakamoto, Yasutoshi; Miki, Izumi; Kobayashi, Shin; Yuda, Junichiro; Kageyama, Shun-Ichiro; Nagamine, Michiko; Sakashita, Shingo; Sakamoto, Naoya; Yamashita, Riu; Koga, Yoshikatsu; Bando, Hideaki; Ishii, Genichiro; Kuwata, Takeshi; Park, Woong-Yang; Ohtsu, Atsushi; Yoshino, Takayuki
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy

与NeoRAS野生型转移性结直肠癌相关的临床特征scrum-japan GOZILA子研究

NATURE COMMUNICATIONS
IF15.7
2024-07-131
OAAI
Osumi, Hiroki; Shinozaki, Eiji; Nakamura, Yoshiaki; Esaki, Taito; Yasui, Hisateru; Taniguchi, Hiroya; Satake, Hironaga; Sunakawa, Yu; Komatsu, Yoshito; Kagawa, Yoshinori; Denda, Tadamichi; Shiozawa, Manabu; Satoh, Taroh; Nishina, Tomohiro; Goto, Masahiro; Takahashi, Naoki; Kato, Takeshi; Bando, Hideaki; Yamaguchi, Kensei; Yoshino, Takayuki

研究方向

暂未获取到该数据
S
Satoshi Yuki
H 指数:24论文数:460被引数:2,246
T
Takayuki Yoshino
H 指数:88论文数:1,566被引数:4.9万
Y
Yasuyuki Kawamoto
H 指数:18论文数:218被引数:1,877
K
Kazuaki Harada
H 指数:9论文数:155被引数:250
K
Kei Muro
H 指数:80论文数:1,040被引数:4.3万
K
Kentaro Yamazaki
H 指数:46论文数:557被引数:1.4万
N
Naoya Sakamoto
H 指数:61论文数:841被引数:1.8万
H
Hideaki Bando
H 指数:42论文数:595被引数:7,335
E
Eiji Oki
H 指数:70论文数:1,185被引数:1.8万
T
Takeshi Kato
H 指数:49论文数:664被引数:7,878